FOI 25-0063 LD State And Territory Chief Health Officers’ Comments On Draft Biotoxins Clinical Pathway, 2023

Written by Claude Haiku 4.5 from the extracted text on 27 Feb 2026. It can miss or misread redacted and scanned pages. Check the source before relying on it.

The Australian Health Protection Principal Committee endorsed finalization of the Biotoxins (indoor damp and mould) Clinical Pathway in March 2023, developed in consultation with the Biotoxin-related Illnesses Advisory Committee. The pathway includes a clinical algorithm flowchart to guide general practitioners through differential diagnosis, evaluation, and referral decisions for biotoxin-related illnesses, plus summary sections on initial assessment, patient management, and diagnostic testing. The document was designed to standardize clinical practice, improve health outcomes, and reduce variations in managing biotoxin-related conditions while supporting vulnerable populations. The Department planned ministerial approval for public website publication alongside an accompanying evidence evaluation report, with state and territory chief health officers to receive weblinks for distribution to their networks.